Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Innospec Inc.NASDAQ: IOSP
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization declines year over year
Q2 FY2026 depreciation & amortization of $10M fell 9.9% year over year, behind the -5.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.0% from the prior quarter. Over 3 fiscal years it compounded at +2.8% a year.
Context
- Depreciation & amortization amounted to 2.5% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -9.9% toward the trailing-twelve-month pace of -5.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 43.6M USD
- Year-over-year change
- +0.2%
- 4-year CAGR
- +0.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 43.6M | +0.2% |
| FY2024 | 2024-12-31 | 43.5M | +10.7% |
| FY2023 | 2023-12-31 | 39.3M | -2.0% |
| FY2022 | 2022-12-31 | 40.1M | -6.1% |
| FY2021 | 2021-12-31 | 42.7M | — |
Depreciation & Amortization vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's LTM Jun 2026 depreciation & amortization of $41.5M is the 9th largest of the 10 companies compared; the peer median is $138.46M.
- Its year-over-year change of -5.7% is the 8th highest of 10, against a peer median of +8.0%.
- Depreciation & amortization amounts to 2.3% of revenue for IOSP, versus a peer median of 5.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $523M | +2.8% | +2.5% | 5.9% | |
| LTM Jun 2026 | $191M | -33.2% | -0.6% | 10.4% | |
| LTM Jun 2026 | $180M | +19.2% | +1.8% | 5.0% | |
| LTM Sep 2026 | $148.8M | +4.0% | +14.8% | 2.9% | |
| LTM Aug 2026 | $138.46M | -22.6% | +6.7% | 3.9% | |
| LTM Jun 2026 | $128.61M | +8.0% | +14.2% | 4.7% | |
| LTM Sep 2026 | $101.38M | +13.4% | +5.1% | 5.0% | |
| LTM Sep 2026 | $55.23M | +19.4% | +24.2% | 4.8% | |
| LTM Jun 2026 | $41.5M | -5.7% | +2.8% | 2.3% | |
| LTM Mar 2026 | $9.89M | +10.8% | -2.6% | 9.0% | |
| Peer median (excluding IOSP) | $138.46M | +8.0% | +5.1% | 5.0% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Depreciation & Amortization | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M |
| Deferred Income Tax | 6.4M | (5.5M) | 3.6M | (39.3M) | (10.2M) |
| Stock-Based Compensation | 4.4M | 6.7M | 8M | 8.5M | 8.1M |
| Change in Working Capital | (48.1M) | (90.1M) | 20.6M | (18.9M) | (48.4M) |
| Accounts Receivables | (31.4M) | (55.5M) | (12.6M) | 4.3M | 21.6M |
| Inventory | (62M) | (98.5M) | 83M | (11.8M) | (6.6M) |
| Accounts Payables | 90.2M | 54.2M | (26.9M) | (4.5M) | (32.8M) |
| Other Working Capital | (44.9M) | 9.7M | (22.9M) | (6.9M) | (30.6M) |
| Other Non-Cash Items | (5.3M) | (2.5M) | (3.3M) | 155.1M | 28.6M |
| Operating Cash Flow | 93.2M | 81.7M | 207.3M | 184.5M | 138.3M |
| Capital Expenditures | (39.1M) | (42.3M) | (62.1M) | (41.4M) | (50.3M) |
| Acquisitions (Net) | 3M | 2M | (34.7M) | (200K) | (700K) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (100K) | (1.8M) | 100K | 500K | (24.1M) |
| Investing Cash Flow | (36.2M) | (42.1M) | (111.8M) | (62M) | (75.1M) |
| Debt Repayment | (600K) | (100K) | (2.3M) | 0 | 0 |
| Common Stock Issued | 10.1M | 2.2M | 900K | 2.1M | 500K |
| Common Stock Repurchased | (800K) | (5.9M) | (1.1M) | (700K) | (23.9M) |
| Dividends Paid | (28.8M) | (31.7M) | (35.1M) | (38.8M) | (42.4M) |
| Other Financing Activities | 100K | 1.8M | (1.4M) | 2.1M | 1.9M |
| Financing Cash Flow | (20M) | (33.7M) | (39M) | (35.3M) | (63.9M) |
| Effect of Forex Changes | (500K) | (600K) | 100K | (1.7M) | 4M |
| Net Change in Cash | 36.5M | 5.3M | 56.6M | 85.5M | 3.3M |
| Free Cash Flow | 54.1M | 39.4M | 145.2M | 143.1M | 88M |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.